These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 19816516)

  • 1. A case of diffuse fluorescein leakage not associated with a CNV in Pseudoxanthoma elasticum.
    Finger RP; Charbel Issa P; Holz FG; Scholl HP
    Eye (Lond); 2010 Jun; 24(6):1111-3. PubMed ID: 19816516
    [No Abstract]   [Full Text] [Related]  

  • 2. Fundus autofluorescence in patients with pseudoxanthoma elasticum.
    Sawa M; Ober MD; Freund KB; Spaide RF
    Ophthalmology; 2006 May; 113(5):814-20.e2. PubMed ID: 16650677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual Impairment in Pseudoxanthoma Elasticum: A Survey of 40 Patients.
    Orssaud C; Roche O; Dufier JL; Germain DP
    Ophthalmic Genet; 2015; 36(4):327-32. PubMed ID: 24749718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal ranibizumab for myopic choroidal neovascularization: factors predictive of visual outcome and need for retreatment.
    Calvo-Gonzalez C; Reche-Frutos J; Donate J; Fernandez-Perez C; Garcia-Feijoo J
    Am J Ophthalmol; 2011 Mar; 151(3):529-34. PubMed ID: 21236413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal fundus imaging of pseudoxanthoma elasticum.
    Zweifel SA; Imamura Y; Freund KB; Spaide RF
    Retina; 2011 Mar; 31(3):482-91. PubMed ID: 20966826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundus autofluorescence.
    Querques G; delle Noci N
    Ophthalmology; 2007 Jun; 114(6):1233; author reply 1233. PubMed ID: 17544787
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravitreal bevacizumab in choroidal neovascularization secondary to Grönblad-Strandberg syndrome: case report.
    Japiassú RM; Japiassú MA; Pecego MG
    Arq Bras Oftalmol; 2008; 71(3):427-9. PubMed ID: 18641836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal ranibizumab for choroidal neovascularization in angioid streaks.
    Mimoun G; Tilleul J; Leys A; Coscas G; Soubrane G; Souied EH
    Am J Ophthalmol; 2010 Nov; 150(5):692-700.e1. PubMed ID: 20719301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization.
    Khurana RN; Dupas B; Bressler NM
    Ophthalmology; 2010 Jul; 117(7):1376-80. PubMed ID: 20452027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fundus autofluorescence in Pseudoxanthoma elasticum.
    Finger RP; Charbel Issa P; Ladewig M; Götting C; Holz FG; Scholl HP
    Retina; 2009; 29(10):1496-505. PubMed ID: 19823106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anty-VEGF therapy in the treatment of myopic macular choroidal neovascularization--cases report].
    Figurska M; Stankiewicz A
    Klin Oczna; 2008; 110(10-12):387-91. PubMed ID: 19195173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective occlusion of subfoveal choroidal neovascularization in angioid streaks by using a new technique of ingrowth site treatment.
    Costa RA; Calucci D; Cardillo JA; Farah ME
    Ophthalmology; 2003 Jun; 110(6):1192-203. PubMed ID: 12799247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia.
    Lalloum F; Souied EH; Bastuji-Garin S; Puche N; Querques G; Glacet-Bernard A; Coscas G; Soubrane G; Leveziel N
    Retina; 2010 Mar; 30(3):399-406. PubMed ID: 20038864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited long-term efficacy of intravitreous anti-VEGF pharmacotherapy in sarcoidosis complicated by peripapillary choroidal neovascular membrane.
    Shah SP; Hubschman JP; Bourges JL; Hu AY; Schwartz SD
    Acta Ophthalmol; 2010 Sep; 88(6):e243-4. PubMed ID: 19740129
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
    Kaiser PK; Blodi BA; Shapiro H; Acharya NR;
    Ophthalmology; 2007 Oct; 114(10):1868-75. PubMed ID: 17628683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal ranibizumab for choroidal neovascularization secondary to acute multifocal posterior placoid pigment epitheliopathy.
    Mavrakanas N; Mendrinos E; Tabatabay C; Pournaras CJ
    Acta Ophthalmol; 2010 Mar; 88(2):e54-5. PubMed ID: 19489761
    [No Abstract]   [Full Text] [Related]  

  • 17. Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.
    Stangos AN; Gandhi JS; Nair-Sahni J; Heimann H; Pournaras CJ; Harding SP
    Am J Ophthalmol; 2010 Nov; 150(5):666-73. PubMed ID: 20719300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal ranibizumab for choroidal neovascularisation in serpiginous choroiditis.
    Song MH; Roh YJ
    Eye (Lond); 2009 Sep; 23(9):1873-5. PubMed ID: 18989340
    [No Abstract]   [Full Text] [Related]  

  • 19. Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study.
    Sadda SR; Stoller G; Boyer DS; Blodi BA; Shapiro H; Ianchulev T
    Retina; 2010 Oct; 30(9):1390-9. PubMed ID: 20924261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of choroidal vascularisation.
    Lommatzsch A
    Br J Ophthalmol; 2008 Apr; 92(4):445-6. PubMed ID: 18369055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.